Date
Insider
Company
Owned Shares
Shares Traded
Price
Net Total
SELL
30 Apr 2023Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
10,040-6%
682
$9.88
$6,735.64
SELL
30 Apr 2023Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
26,632-4%
1,136
$9.88
$11,219.48
SELL
30 Apr 2023Wolff Stefani
EVP and COO, Officer
Nurix Therapeutics, Inc.
(NRIX)
6,113-5%
342
$9.88
$3,377.69
SELL
30 Apr 2023van Houte Hans
Chief Financial Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
78,930-0%
721
$9.88
$7,120.81
SELL
30 Jan 2023Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
23,009-5%
1,412
$11.78
$16,632.80
SELL
30 Jan 2023van Houte Hans
Chief Financial Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
76,765-1%
924
$11.78
$10,884.35
SELL
30 Jan 2023Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
7,261-10%
848
$11.78
$9,989.10
SELL
30 Jan 2023Wolff Stefani
EVP and COO, Officer
Nurix Therapeutics, Inc.
(NRIX)
3,940-9%
424
$11.78
$4,994.55
SELL
30 Oct 2022Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
21,214-5%
1,165
$12.88
$15,005.78
SELL
30 Oct 2022Wolff Stefani
EVP and COO, Officer
Nurix Therapeutics, Inc.
(NRIX)
3,402-9%
350
$12.88
$4,508.18
SELL
30 Oct 2022van Houte Hans
Chief Financial Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
74,803-0%
739
$12.88
$9,518.69
SELL
30 Oct 2022Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
6,185-10%
699
$12.88
$9,003.47
SELL
30 Jul 2022Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
4,615-13%
712
$15.67
$11,157.04
SELL
30 Jul 2022Wolff Stefani
EVP and COO, Officer
Nurix Therapeutics, Inc.
(NRIX)
1,238-22%
356
$15.67
$5,578.52
SELL
30 Jul 2022van Houte Hans
Chief Financial Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
72,656-1%
752
$15.67
$11,783.84
SELL
30 Jul 2022Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
19,172-5%
1,186
$15.67
$18,584.62
SELL
30 Apr 2022Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
17,151-6%
1,098
$11.75
$12,901.50
SELL
30 Apr 2022Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
3,403-16%
660
$11.75
$7,755.00
SELL
30 Apr 2022Wolff Stefani
EVP and COO, Officer
Nurix Therapeutics, Inc.
(NRIX)
632-34%
330
$11.75
$3,877.50
SELL
30 Apr 2022van Houte Hans
Chief Financial Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
2,189-24%
697
$11.75
$8,189.75
SELL
10 Jan 2022Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
1,286-48%
1,200
$27.14
$32,568.00
SELL
3 Jan 2022Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
14,197-11%
1,828
$28.96
$52,938.88
SELL
10 Dec 2021Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
1,286-48%
1,200
$29.04
$34,848.00
SELL
1 Dec 2021Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
14,197-2%
400
$29.13
$11,652.00
SELL
10 Nov 2021Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
1,286-48%
1,200
$32.38
$38,856.00
SELL
1 Nov 2021Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
14,197-2%
400
$33.24
$13,296.00
SELL
27 Oct 2021Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
14,197-2%
400
$35.00
$14,000.00
SELL
27 Oct 2021Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
1,286-38%
800
$35.25
$28,200.00
SELL
11 Oct 2021Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
1,286-48%
1,200
$27.36
$32,832.00
SELL
1 Oct 2021Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
14,197-2%
400
$29.92
$11,968.00
SELL
10 Sep 2021Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
2,586-43%
2,000
$35.93
$71,860.16
SELL
7 Sep 2021Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
14,197-10%
1,600
$35.00
$56,000.00
SELL
7 Sep 2021Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
1,286-71%
3,200
$35.25
$112,800.00
SELL
1 Sep 2021Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
14,197-2%
400
$32.34
$12,936.00
SELL
10 Aug 2021Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
805-59%
1,200
$29.87
$35,844.96
SELL
10 Aug 2021Beaurang Pierre
Chief Business Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
6,210-54%
7,500
$29.86
$223,925.94
SELL
2 Aug 2021Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
13,804-2%
400
$31.21
$12,484.00
SELL
20 Jul 2021Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
805-59%
1,200
$27.00
$32,400.00
SELL
12 Jul 2021Beaurang Pierre
Chief Business Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
4,730-61%
7,500
$23.92
$179,418.70
SELL
1 Jul 2021Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
13,804-2%
400
$26.76
$10,704.00
SELL
10 Jun 2021Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
1,005-54%
1,200
$29.40
$35,282.00
SELL
10 Jun 2021Beaurang Pierre
Chief Business Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
5,830-56%
7,500
$29.37
$220,248.50
SELL
1 Jun 2021Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
13,804-2%
400
$27.74
$11,096.00
SELL
10 May 2021Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
805-59%
1,200
$27.00
$32,400.00
SELL
10 May 2021Beaurang Pierre
Chief Business Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
7,531-49%
7,500
$26.49
$198,644.22
SELL
3 May 2021Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
13,804-5%
800
$35.00
$27,996.00
SELL
28 Apr 2021Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
805-49%
800
$35.25
$28,200.00
SELL
12 Apr 2021Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
805-59%
1,200
$27.20
$32,640.00
SELL
12 Apr 2021Beaurang Pierre
Chief Business Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
7,758-49%
7,500
$27.28
$204,631.89
SELL
5 Apr 2021Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
13,804-2%
400
$35.00
$14,000.00
SELL
1 Apr 2021Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
13,804-2%
400
$31.55
$12,620.00
SELL
16 Mar 2021Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
13,804-5%
800
$45.00
$36,000.00
SELL
10 Mar 2021Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
1,905-51%
2,000
$41.27
$82,539.37
SELL
8 Mar 2021Beaurang Pierre
Chief Business Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
4,690-61%
7,500
$37.02
$277,678.50
SELL
1 Mar 2021Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
13,804-5%
800
$35.95
$28,760.00
SELL
24 Feb 2021van Houte Hans
Chief Financial Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
0-100%
35,419
$39.90
$1,413,218.10
SELL
22 Feb 2021van Houte Hans
Chief Financial Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
0-100%
5,330
$39.93
$212,839.16
SELL
18 Feb 2021Hansen Gwenn
Chief Scientific Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
12,200-6%
800
$36.27
$29,018.02
SELL
18 Feb 2021Ring Christine
General Counsel, Officer
Nurix Therapeutics, Inc.
(NRIX)
1,600-55%
2,000
$35.88
$71,750.35
SELL
18 Feb 2021Beaurang Pierre
Chief Business Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
12,353-54%
15,000
$35.49
$532,351.75
SELL
18 Feb 2021van Houte Hans
Chief Financial Officer, Officer
Nurix Therapeutics, Inc.
(NRIX)
10,443-56%
13,583
$35.46
$481,621.03